Craft
Zogenix

Zogenix

Revenue

$81.7 M

FY, 2021

Market Capitalization

$1.5 B

2022-03-04

Zogenix Summary

Company summary

Overview
Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
Type
Public
Founded
2006
HQ
Emeryville, CA, US | view all locations
Website
http://www.zogenix.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Stephen J. Farr

    Stephen J. Farr, President and Chief Executive Officer, Co-Founder, Director

    • Gail M. Farfel

      Gail M. Farfel, Executive Vice President and Chief Development Officer

      • Bradley S. Galer

        Bradley S. Galer, Executive Vice President and Chief Medical Officer

        • Ashish Sagrolikar

          Ashish Sagrolikar, Executive Vice President and Chief Commercial Officer

          LocationsView all

          2 locations detected

          • Emeryville, CA HQ

            United States

            5959 Horton St 5th Floor

          • Maidenhead, England

            United Kingdom

            West St

          Zogenix Financials

          Summary financials

          Revenue (FY, 2021)
          $81.7M
          Net income (FY, 2021)
          ($227.4M)
          Cash (FY, 2021)
          $101.2M
          EBIT (FY, 2021)
          ($224.1M)

          Footer menu